SKHY SK hynix Inc

SK hynix Inc (SKHY) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On a capital return basis, ROIC is 65.58%, WACC is 17.01%, and the economic spread is 48.57%. On balance, the company is compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 101.69% and ROA at 56.47%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

On valuation, the company registers trailing P/E of 9.50, forward P/E of 4.36, PEG of 0.36. The spread between the two P/E figures is moderate, suggesting earnings are expected to improve gradually rather than accelerate sharply. The PEG reading suggests the market is pricing growth conservatively — a dynamic that can be favorable if earnings estimates prove accurate. A current ratio of 2.59 across the company reflects strong short-term liquidity. Taken together, the multiple and liquidity picture suggests a company that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Stripping to unit economics, gross margin sits at 76.07%, operating margin at 68.03%, and free cash flow margin at 48.47%. Gross margins are exceptional, reflecting strong pricing power and a defensible cost structure. At this operating margin level, the company demonstrates strong operational discipline and meaningful earnings leverage. The company's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Read in combination, these margins suggest a business model that protects profitability across multiple cost layers.

Connecting operational trends with market expectations, TTM revenue growth of 256.78% indicating strong organic momentum at the company level, while the estimated 12-month price change of 80.45%, where consensus targets imply substantial appreciation potential over the next 12 months. At 117.9%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.